NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals NBY
$ 0.09 1.48%

NovaBay Pharmaceuticals Cost of Revenue 2011-2024 | NBY

Annual Cost of Revenue NovaBay Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.83 M 6.62 M 3.69 M 3.97 M 1.74 M 1.5 M 2.78 M 2.46 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.83 M 1.5 M 3.7 M

Quarterly Cost of Revenue NovaBay Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
837 K - 1.43 M 2.3 M 739 K - 1.45 M 1.82 M 1.46 M - 712 K 614 K 455 K - 536 K 2.04 M 581 K - 401 K 403 K 341 K - 332 K 479 K 251 K - 521 K 698 K 588 K - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.3 M 251 K 863 K